{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:42:53Z","timestamp":1790170973545,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01-HL131872"],"award-info":[{"award-number":["R01-HL131872"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01-HL122805"],"award-info":[{"award-number":["R01-HL122805"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AHA GRANT","award":["24810002"],"award-info":[{"award-number":["24810002"]}]},{"name":"The Kibel Fund for Aortic Valve Research"},{"name":"The Valley Hospital Foundation"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32-HL007954"],"award-info":[{"award-number":["T32-HL007954"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32-HL007915"],"award-info":[{"award-number":["T32-HL007915"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Barth Memorial Mitral Valve Disease Fund"},{"name":"Erin's Fund"},{"name":"William J. Rashkind Endowment of the Children's Hospital of Philadelphia"}],"content-domain":{"domain":["jmmc-online.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.yjmcc.2017.12.014","type":"journal-article","created":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T21:41:13Z","timestamp":1514583673000},"page":"94-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Serotonin receptor 2B signaling with interstitial cell activation and leaflet remodeling in degenerative mitral regurgitation"],"prefix":"10.1016","volume":"115","author":[{"given":"Kathryn H.","family":"Driesbaugh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Branchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan B.","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J.","family":"Keeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Rioux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Sacks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Quackenbush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2017.12.014_bb0005","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1002\/jcp.22999","article-title":"Human myxomatous mitral valve prolapse: role of bone morphogenetic protein 4 in valvular interstitial cell activation","volume":"227","author":"Sainger","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-med-022811-091602","article-title":"Mitral valve prolapse","volume":"63","author":"Guy","year":"2012","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0015","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S0002-9149(02)02340-8","article-title":"Mitral valve prolapse and atrial septal aneurysm: an evaluation in the Framingham Heart Study","volume":"89","author":"Freed","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0020","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.jacc.2014.02.537","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0025","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s12265-011-9318-7","article-title":"Cellular mechanisms in mitral valve disease","volume":"4","author":"Salhiyyah","year":"2011","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-physiol-012110-142145","article-title":"Heart valve structure and function in development and disease","volume":"73","author":"Hinton","year":"2011","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0035","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1586\/14779072.2014.923756","article-title":"Molecular biology of calcific aortic valve disease: towards new pharmacological therapies","volume":"12","author":"Mathieu","year":"2014","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0040","first-page":"218","article-title":"Potential drug targets for calcific aortic valve disease","volume":"11","author":"Hutcheson","year":"2014","journal-title":"Nat. Publ. Group"},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0045","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/CIRCULATIONAHA.110.006767","article-title":"Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the national heart and lung and blood institute aortic stenosis working group * executive summary: calcific aortic valve disease - 2011 update","volume":"124","author":"Rajamannan","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0050","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/cvr\/cvt055","article-title":"Noggin attenuates the osteogenic activation of human valve interstitial cells in aortic valve sclerosis","volume":"98","author":"Poggio","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0055","first-page":"e66","article-title":"Antioxidant enzymes reduce DNA damage and early activation of valvular interstitial cells in aortic valve sclerosis","volume":"33","author":"Branchetti","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0060","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.113.303017","article-title":"Osteopontin-CD44v6 interaction mediates calcium deposition via Phospho-Akt in valve interstitial cells from patients with noncalcified aortic valve sclerosis","author":"Poggio","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0065","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1002\/jcp.22549","article-title":"Osteopontin controls endothelial cell migration in vitro and in excised human valvular tissue from patients with calcific aortic stenosis and controls","volume":"226","author":"Poggio","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.athoracsur.2011.08.036","article-title":"Analysis of osteopontin levels for the identification of asymptomatic patients with calcific aortic valve disease","volume":"93","author":"Grau","year":"2012","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0075","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s10439-014-0973-0","article-title":"Architectural trends in the human normal and bicuspid aortic valve leaflet and its relevance to valve disease","volume":"42","author":"Aggarwal","year":"2014","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0080","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1161\/ATVBAHA.114.303784","article-title":"Circulating soluble receptor for advanced glycation end product identifies patients with bicuspid aortic valve and associated aortopathies","volume":"34","author":"Branchetti","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0085","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1002\/jcp.22999","article-title":"Human myxomatous mitral valve prolapse: role of bone morphogenetic protein 4 in valvular interstitial cell activation","volume":"227","author":"Sainger","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0090","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.athoracsur.2006.03.117","article-title":"In-vivo dynamic deformation of the mitral valve anterior leaflet","volume":"82","author":"Sacks","year":"2006","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0095","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jtbi.2015.03.004","article-title":"Quantification and simulation of layer-specific mitral valve interstitial cells deformation under physiological loading","volume":"373","author":"Lee","year":"2015","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/CIRCULATIONAHA.105.593459","article-title":"Serotonin transporter mechanisms and cardiac disease","volume":"113","author":"Levy","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1939-1676.2009.0411.x","article-title":"Insights into serotonin signaling mechanisms associated with canine degenerative mitral valve disease","volume":"24","author":"Oyama","year":"2010","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0110","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0002-9440(10)64489-6","article-title":"Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells","volume":"161","author":"Jian","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0115","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/S0002-9440(10)64497-5","article-title":"Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells","volume":"161","author":"Xu","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0120","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2353\/ajpath.2009.081101","article-title":"Fenfluramine disrupts the mitral valve interstitial cell response to serotonin","volume":"175","author":"Connolly","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0125","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1939-1676.2009.0378.x","article-title":"Serum serotonin concentrations in dogs with degenerative mitral valve disease","volume":"23","author":"Arndt","year":"2009","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pcad.2006.12.002","article-title":"Carcinoid heart disease","volume":"49","author":"Bernheim","year":"2007","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0135","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0140-6736(09)60252-X","article-title":"Drug-induced fibrotic valvular heart disease","volume":"374","author":"Bhattacharyya","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0140","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1369\/jhc.4A6500.2005","article-title":"5-Hydroxytryptamine (5HT) receptors in the heart valves of cynomolgus monkeys and Sprague-Dawley rats","volume":"53","author":"Elangbam","year":"2005","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0145","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0074-7742(09)88010-0","article-title":"Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA)","volume":"88","author":"Baumann","year":"2009","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0150","doi-asserted-by":"crossref","first-page":"779","DOI":"10.7326\/0003-4819-136-10-200205210-00016","article-title":"Anorexogen-related cardiac valvulopathy","volume":"136","author":"Rothman","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0155","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/01.CIR.102.23.2836","article-title":"Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications","volume":"102","author":"Rothman","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0160","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1124\/mol.104.009266","article-title":"Molecular determinants for the interaction of the valvulopathic anorexigen norfenfluramine with the 5-HT2B receptor","volume":"68","author":"Setola","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0165","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.etp.2008.03.005","article-title":"5-hydroxytryptamine (5HT)-induced valvulopathy: compositional valvular alterations are associated with 5HT2B receptor and 5HT transporter transcript changes in Sprague-Dawley rats","volume":"60","author":"Elangbam","year":"2008","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/CIRCULATIONAHA.105.554667","article-title":"Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice","volume":"113","author":"Mekontso-Dessap","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0175","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/01.CIR.0000159356.42064.48","article-title":"Long-term serotonin administration induces heart valve disease in rats","volume":"111","author":"Gustafsson","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0180","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.regpep.2007.02.009","article-title":"Long-term serotonin effects in the rat are prevented by terguride","volume":"143","author":"Hauso","year":"2007","journal-title":"Regul. Pept."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0185","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5-HT receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0190","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1021\/cr078224o","article-title":"Serotonin receptors","volume":"108","author":"Nichols","year":"2008","journal-title":"Chem. Rev."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0195","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.114.000921","article-title":"Non-biased molecular screening identifies novel molecular regulators of fibrogenic and proliferative signaling in myxomatous mitral valve disease","author":"Thalji","year":"2015","journal-title":"Circulation Cardiovasc. Genet."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0200","first-page":"1","article-title":"Passing messages between biological networks to refine predicted interactions","author":"Kimberly","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0205","doi-asserted-by":"crossref","first-page":"H224","DOI":"10.1152\/ajpheart.00521.2005","article-title":"Correlation between heart valve interstitial cell stiffness and transvalvular pressure: implications for collagen biosynthesis","volume":"290","author":"Merryman","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0210","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1089\/ten.2006.0324","article-title":"Differences in tissue-remodeling potential of aortic and pulmonary heart valve interstitial cells","volume":"13","author":"Merryman","year":"2007","journal-title":"Tissue Eng."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0215","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/cvr\/cvt205","article-title":"Oxidative stress modulates vascular smooth muscle cell phenotype via CTGF in thoracic aortic aneurysm","volume":"100","author":"Branchetti","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0220","first-page":"131","article-title":"LY272015, a potentm selective and orally active 5HT2B receptor antagonist","volume":"3","author":"Cohen","year":"1996","journal-title":"J. Serotonin Res."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0225","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2460\/ajvr.67.8.1307","article-title":"Genomic expression patterns of mitral valve tissues from dogs with degenerative mitral valve disease","volume":"67","author":"Oyama","year":"2006","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0230","first-page":"44","article-title":"Autocrine serotonin and transforming growth factor beta 1 signaling mediates spontaneous myxomatous mitral valve disease","volume":"18","author":"Disatian","year":"2009","journal-title":"J. Heart Valve Dis."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0235","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1161\/CIRCULATIONAHA.111.082610","article-title":"Modulation of transforming growth factor-\u03b2 signaling and extracellular matrix production in myxomatous mitral valves by angiotensin II receptor blockers","volume":"126","author":"Geirsson","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0240","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tvjl.2015.02.021","article-title":"Gene network and canonical pathway analysis in canine myxomatous mitral valve disease: a microarray study","volume":"204","author":"Lu","year":"2015","journal-title":"Vet. J."},{"key":"10.1016\/j.yjmcc.2017.12.014_bb0245","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pharmthera.2011.03.013","article-title":"Ontogeny and regulation of the serotonin transporter: providing insights into human disorders","volume":"131","author":"Daws","year":"2011","journal-title":"Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.yjmcc.2017.12.014_bb5000","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1002\/stem.1777","article-title":"Serotonin enhances megakaryopoiesis and proplatelet formation via p-Erk1\/2 and F-actin reorganization","volume":"32","author":"Ye","year":"2014","journal-title":"Stem Cells"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002228281730370X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002228281730370X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T23:53:19Z","timestamp":1574985199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002228281730370X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":50,"alternative-id":["S002228281730370X"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2017.12.014","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serotonin receptor 2B signaling with interstitial cell activation and leaflet remodeling in degenerative mitral regurgitation","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2017.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}